Phocas Financial Corp’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.59M	Sell	114,413 -32,122	-22%	-$714K	0.41%	103
2025 Q4	$3.79M	Sell	146,535 -368	-0.3%	-$8.75K	0.49%	84
2025 Q3	$3.79M	Sell	146,903 -46,534	-24%	-$1.14M	0.49%	81
2025 Q2	$4.62M	Buy	193,437 +50,994	+36%	+$1.29M	0.66%	69
2025 Q1	$3.54M	Buy	+142,443	New	+$3.41M	0.54%	76
2023 Q4	–	Sell	-44,131	Closed	-$1.35M	–	182
2023 Q3	$1.35M	Sell	44,131 -89,064	-67%	-$3.21M	0.2%	122
2023 Q2	$5.34M	Buy	133,195 +36,839	+38%	+$1.52M	0.73%	58
2023 Q1	$3.93M	Buy	96,356 +942	+1%	+$37.5K	0.56%	76
2022 Q4	$3.68M	Sell	95,414 -29	-0%	-$1.41K	0.53%	81
2022 Q3	$5.08M	Buy	95,443 +3,028	+3%	+$168K	0.79%	53
2022 Q2	$5.39M	Sell	92,415 -1,033	-1%	-$67.7K	0.81%	58
2022 Q1	$7.13M	Buy	+93,448	New	+$6.23M	0.9%	40